being and becoming in the world
In the USA, pharmaceutical and medical device companies are required by law to release details of their payments to a variety of doctors and U.S. teaching hospitals for promotional talks, … Continue reading Learning from the USA
The following post was written by me exactly 2 years ago. I was reminded of it when peacefully protesting, once again, outside the International Congress of the Royal College of … Continue reading The Royal College of Psychiatrists: Who is wagging the dog’s tail?
This paid opinion leader, like all paid opinion leaders, has chosen to ignore repeated research which has established that commercial interests are one of the major determinants of BIAS in … Continue reading A psychiatrist and paid opinion leader says:
My wife wrote down these notes after reading this published opinion: Please read this for more.
May 2023: When interviewed* for this podcast about antidepressants Professor Carmine Pariante said: “It is important that when we have this media debate it is always balanced”. June 2024: Professor … Continue reading “It is important that when we have this media debate it is always balanced”
The lawsuit: Csoka v. FDA “We represent Dr. Antonei B. Csoka in a case against the U.S. Food and Drug Administration (FDA) seeking to compel the FDA to act on … Continue reading Prescribed drugs linked to long-term sexual dysfunction
This is one of the educational seminars to be held at the RCPsych International Congress in Edinburgh, in June of this year: [spelling mistakes as per conference programme] Our family … Continue reading Are neurotransmitters passé in psychiatry?
This is one of the educational seminars to be held at the RCPsych International Congress in Edinburgh, in June of this year: I worked as an NHS psychiatrist for over … Continue reading Ten things every psychiatrist should (hopefully) know . . .